PHAXIAM Therapeutics SA (PHXM) EBIT

PHXM Annual EBIT

$645.40 K
+$61.76 M+101.06%

31 December 2022

PHXM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PHXM Quarterly EBIT

-$5.85 M
0.00%

30 September 2023

PHXM Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PHXM TTM EBIT

-$3.75 M
0.00%

30 September 2023

PHXM TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PHXM EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+101.1%-378.5%-2515.3%
3 y3 years+100.9%-378.5%-2515.3%
5 y5 years+101.7%-378.5%-2515.3%

PHXM EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time-82.6%-137.5%-2515.3%

PHAXIAM Therapeutics SA EBIT History

DateAnnualQuarterlyTTM
Sept 2023
-
-$5.85 M(-378.5%)
-$3.75 M(-2515.3%)
Dec 2022
$645.40 K(-101.1%)
$2.10 M(-147.1%)
$155.30 K(-101.0%)
Sept 2022
-
-$4.46 M(-128.6%)
-$16.18 M(-38.8%)
June 2022
-
$15.61 M(-219.2%)
-$26.45 M(-56.5%)
Mar 2022
-
-$13.10 M(-8.0%)
-$60.77 M(-0.6%)
Dec 2021
-$61.12 M(-24.8%)
-$14.23 M(-3.4%)
-$61.16 M(-13.9%)
Sept 2021
-
-$14.73 M(-21.2%)
-$71.02 M(-5.6%)
June 2021
-
-$18.70 M(+38.6%)
-$75.23 M(-0.4%)
Mar 2021
-
-$13.49 M(-44.0%)
-$75.54 M(-7.1%)
Dec 2020
-$81.24 M
-$24.10 M(+27.2%)
-$81.32 M(+3.5%)
Sept 2020
-
-$18.94 M(-0.4%)
-$78.60 M(+4.7%)
June 2020
-
-$19.01 M(-1.4%)
-$75.08 M(-0.7%)
Mar 2020
-
-$19.28 M(-9.8%)
-$75.62 M(+8.8%)
DateAnnualQuarterlyTTM
Dec 2019
-
-$21.38 M(+38.6%)
-$69.52 M(+20.0%)
Dec 2019
-$69.60 M(+54.2%)
-
-
Sept 2019
-
-$15.42 M(-21.1%)
-$57.93 M(+5.4%)
June 2019
-
-$19.55 M(+48.4%)
-$54.94 M(+55.2%)
Mar 2019
-
-$13.18 M(+34.7%)
-$35.39 M(+59.3%)
Dec 2018
-
-$9.78 M(-21.3%)
-$22.21 M(+78.7%)
Dec 2018
-$45.12 M(+18.9%)
-
-
Sept 2018
-
-$12.43 M
-$12.43 M
Dec 2017
-$37.96 M(+56.6%)
-
-
Dec 2016
-$24.24 M(+45.7%)
-
-
Dec 2015
-$16.63 M(+40.9%)
-
-
Dec 2014
-$11.80 M(+24.8%)
-
-
Dec 2013
-$9.46 M(+241.3%)
-
-
Dec 2012
-$2.77 M
-
-

FAQ

  • What is PHAXIAM Therapeutics SA annual earnings before interest & taxes?
  • What is the all time high annual EBIT for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA annual EBIT year-on-year change?
  • What is PHAXIAM Therapeutics SA quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA quarterly EBIT year-on-year change?
  • What is PHAXIAM Therapeutics SA TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA TTM EBIT year-on-year change?

What is PHAXIAM Therapeutics SA annual earnings before interest & taxes?

The current annual EBIT of PHXM is $645.40 K

What is the all time high annual EBIT for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high annual earnings before interest & taxes is $3.71 M

What is PHAXIAM Therapeutics SA annual EBIT year-on-year change?

Over the past year, PHXM annual earnings before interest & taxes has changed by +$61.76 M (+101.06%)

What is PHAXIAM Therapeutics SA quarterly earnings before interest & taxes?

The current quarterly EBIT of PHXM is -$5.85 M

What is the all time high quarterly EBIT for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high quarterly earnings before interest & taxes is $15.61 M

What is PHAXIAM Therapeutics SA quarterly EBIT year-on-year change?

Over the past year, PHXM quarterly earnings before interest & taxes has changed by -$7.95 M (-378.50%)

What is PHAXIAM Therapeutics SA TTM earnings before interest & taxes?

The current TTM EBIT of PHXM is -$3.75 M

What is the all time high TTM EBIT for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high TTM earnings before interest & taxes is $155.30 K

What is PHAXIAM Therapeutics SA TTM EBIT year-on-year change?

Over the past year, PHXM TTM earnings before interest & taxes has changed by -$3.91 M (-2515.26%)